Chinese Upcoming Revised Foreign Investment Catalogue Will Continue To Promote Innovative Drug R&D
This article was originally published in PharmAsia News
Executive SummarySHANGHAI - China's State Council recently announced a plan to revise its Catalogue of Foreign Investment, which guides foreign investment and is, with this edition, opening more high-technology industries to foreign investment to encourage foreign companies to merge with and acquire Chinese firms engaged in high-tech industries
You may also be interested in...
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).